SEC Filings

AVEXIS, INC. filed this Form S-1/A on 02/09/2016
Entire Document

Table of Contents

      to our chairman, $405,000, and an annual option grant to purchase our common stock with an aggregate Black-Scholes option value of $125,000 under our 2016 Equity Incentive Plan; and

    Upon the pricing of this offering, each of our current non-employee directors will receive an initial option grant and an annual option grant at the price per share at which our common stock is sold to the public in this offering.

          All fees under the director compensation policy will be paid in equal quarterly installments and no per meeting fees will be paid. We will also reimburse non-employee directors for reasonable expenses incurred in connection with attending board of director and committee meetings.

Director Compensation Table

          As described above, we did not pay any cash or grant any stock awards or other compensation to our non-employee directors during 2015 for their services as non-employee directors. Except as described below for Dr. Kaspar, there were no outstanding stock awards or option awards held by our non-employee directors as of December 31, 2015. However, the following table sets forth in summary form information concerning the compensation that, pursuant to SEC rules, was paid or awarded during the year ended December 31, 2015 to Dr. Kaspar under the arrangement described above. It also includes compensation attributable to Mr. Harkey and Dr. Genecov resulting from the acceleration of certain stock options held by Mr. Carbona in connection with the termination of his employment.

Awards ($)
All Other
Compensation ($)
Total ($)

John A. Carbona(2)


John D. Harkey, Jr.(3)

    167,684 (5)       167,684  

David G. Genecov M.D.(4)

    167,684 (5)       167,684  

Brian K. Kaspar, Ph.D.(6)

        90,000 (7)   90,000  

Bong Y. Koh(8)


Paul B. Manning


Jonathan Leff


Carole Nuechterlein


Frank Verwiel(9)


On June 8, 2015, Mr. Nolan joined the board in connection with his service as our Chief Executive Officer. Mr. Nolan did not receive any compensation in 2015 for services provided as a member of our board of directors.

Mr. Carbona was an employee director from January 1, 2015 through April 22, 2015 and his compensation during this period in 2015 is fully reflected in "Executive Compensation — Summary Compensation Table" below. From April 23, 2015 through June 15, 2015, Mr. Carbona served as a non-employee director of the Company. Mr. Carbona did not receive any compensation in 2015 for services provided as a member of our board of directors. Mr. Carbona ceased serving on the board on June 15, 2015.

Mr. Harkey ceased serving on the board on October 8, 2015.

Dr. Genecov ceased serving on the board on June 10, 2015.

We did not grant any stock options to our non-employee directors in 2015 for their service on our board of directors. The amounts reported in this column for Mr. Harkey and Dr. Genecov represent, for each director, one-third of the incremental fair value of the modification of the


© AveXis, Inc. All Rights Reserved.